010 Colorectal Cancer Clinical
Colorectal (Clinical)
1. Fadli A, Azmi M, David O, et al. Isolated metacarpal bone metastasis from advanced rectosigmoid
carcinoma. International Medical Journal (IIUM) 2012;11(1):52-62
http://iiumedic.net/imjm/v1/download/Volume%2011%20No%201/IMJM%20Vol11No1-2012p59-62.pdf
2. Magaji BA, Moy FM, April Camilla R, et al. Health-related quality of life among colorectal cancer
patients in Malaysia: a study protocol. BMC Cancer 2012;12:384-2407-12-384
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3443003/
3. Rajendra S, Ho JJ. Colonic diverticular disease in a multiracial Asian patient population has an
ethnic predilection. Eur J Gastroenterol Hepatol 2005;17(8):871-875.
4. Azmi MN, Zailani MA, Norashikin MN, et al. Five-year review of histopathological findings of
colorectal cancer patients operated in Hospital Tengku Ampuan Afzan, Kuantan, Pahang,
Malaysia. International Medical Journal (IIUM) 2007;6(1)
http://www.e-imj.com/Vol6-No1/Vol6-No1-B3.htm
5. Mohamed AQ. Consensus/Clinical Practice Guidelines on Screening for Colorectal Cancer in
Malaysia. Malaysian Society of Gastroenterology & Hepatology, College of Surgeons of Malaysia,
Academy of Medicine of Malaysia 2001;.
6. Qureshi MA. Consensus/Clinical Practice Guidelines on Screening for Colorectal Cancer in
Malaysia. 2001;.
7. Chew MF, Teoh KH, Cheah PL. CD133 marks for colorectal adenocarcinoma. Malays J Pathol
2012;34(1):25-28
http://www.mjpath.org.my/2012.1/CD133.pdf
8. Sharifa Ezat WP, Natrah MS, Syed Mohd A, et al. Quality of life in Malaysian colorectal cancer
patients. Asia Pac Psychiatry 2013;5 Suppl 1:110-117
http://onlinelibrary.wiley.com/doi/10.1111/appy.12055/pdf
9. Loh KW, Hazreen AM, Maznah D, et al. Sociodemographic predictors of recall and recognition of
colorectal cancer symptoms and anticipated delay in help- seeking in a multiethnic asian
population. Asian Pac J Cancer Prev 2013;14(6):3799-3804
http://www.apocpcontrol.org/paper_file/issue_abs/Volume14_No6/3799804%205.19%20Kwong%20Weng%20Loh.pdf
10. 10. Yunus AG. Surgical management of rectal cancer - no room for error. Malaysian Journal of
Medicine and Health Sciences 2008;4(1):iii-iv
http://medic.upm.edu.my/images/stories/journal/VOL4NO1_JANUARY2008.pdf
Page 1 of 10
11. Al-Naggar RA, Bobryshev YV. Knowledge of colorectal cancer screening among young Malaysians.
Asian Pac J Cancer Prev 2013;14(3):1969-1974
http://www.apocpcontrol.org/paper_file/issue_abs/Volume14_No3/%20196974%202.21%20Redhwan%20A%20Al-Naggar.pdf
12. Zahary MN, Ahmad Aizat AA, Gurjeet Kaur, et al. Contribution of the MLH1 -93G>a promoter
polymorphism in modulating susceptibility risk in Malaysian colorectal cancer patients. Asian Pac
J Cancer Prev 2013;14(2):619-624
http://www.apocpcontrol.org/paper_file/issue_abs/Volume14_No2/619-624%208.13%20Zahary
%20Mohd%20Nizam.pdf
13. Harmy MY, Norwati D, Norhayati MN, et al. Participation and barriers to colorectal cancer
screening in Malaysia. Asian Pac J Cancer Prev 2012;13(8):3983-3987
http://www.apocpcontrol.org/paper_file/issue_abs/Volume13_No8/3983-87%207.24%20Harmy
%20Mohamed%20Yusof.pdf
14. 14. Ulaganathan V, Kandiah M, Zalilah MS, et al. Colorectal cancer and its association with the
metabolic syndrome: a Malaysian multi-centric case-control study. Asian Pac J Cancer Prev
2012;13(8):3873-3877
http://www.apocpcontrol.org/paper_file/issue_abs/Volume13_No8/387377%207.16%20Vaidehi%20Ulaganathan.pdf
15. Ashwaq Hamid Y, Narazah MY, Imran AK, et al. Pilot study of the sensitivity and specificity of the
DNA integrity assay for stool-based detection of colorectal cancer in Malaysian patients. Asian
Pac J Cancer Prev 2012;13(5):1869-1872
http://www.apocpcontrol.org/paper_file/issue_abs/Volume13_No5/1869-72%204.1%20Ashwaq
%20Hamid%20Yehya.pdf
16. Al-Jashamy K, Murad A, Zeehaida M, et al. Prevalence of colorectal cancer associated with
Streptococcus bovis among inflammatory bowel and chronic gastrointestinal tract disease
patients. Asian Pac J Cancer Prev 2010;11(6):1765-1768
http://www.apocpcontrol.org/paper_file/issue_abs/Volume11_No6/c%20176568%2010.20%20Al-Jashamy%20Karim.pdf
17. Kong C, April Camilla R, Law C, et al. Impact of socio-economic class on colorectal cancer patient
outcomes in Kuala Lumpur and Kuching, Malaysia. Asian Pac J Cancer Prev 2010;11(4):969-974
http://www.apocpcontrol.org/paper_file/issue_abs/Volume11_No4/c%20969-74%20Kong.pdf
18. Nor Hayati O, Anani Aila MZ. Association of colorectal carcinoma with metabolic diseases;
experience with 138 cases from Kelantan, Malaysia. Asian Pac J Cancer Prev 2008;9(4):747-751
http://www.apocpcontrol.org/paper_file/issue_abs/Volume9_No4/747%20c%20Othman.pdf
Page 2 of 10
19. Mohd Radzniwan AR, Aznida Firzah AA, Saharuddin A, et al. Colorectal cancer patients in a
tertiary referral centre in Malaysia: a five year follow-up review. Asian Pac J Cancer Prev
2009;10(6):1163-1166
http://www.apocpcontrol.org/paper_file/issue_abs/Volume10_No6/1163_c_Rashid.pdf
20. Mirnalini K, Amutha R, Zalilah MS, et al. Diet and lifestyle intervention among patients with
colorectal adenomas: rationale and design of a Malaysian study. Asian Pac J Cancer Prev
2005;6(4):553-560
http://www.apocpcontrol.org/paper_file/issue_abs/Volume6_No4/Mirnalini%20Kandiah.pdf
21. Husna AA, Loh SY, Low WY, et al. Quality of life of multiethnic adolescents living with a parent
with cancer. Asian Pac J Cancer Prev 2012;13(12):6289-6294
http://www.apocpcontrol.org/paper_file/issue_abs/Volume13_No12/628994%2011.10%20Husna%20A%20Ainuddin.pdf
22. Afzaninawati Suria Y, Zaleha MI, Shamsul Azhar Shah. Perceptions of Malaysian colorectal cancer
patients regarding dietary intake: a qualitative exploration. Asian Pac J Cancer Prev
2013;14(2):1151-1154
http://www.apocpcontrol.org/paper_file/issue_abs/Volume14_No2/115154%201.4%20Afzaninawati%20Suria%20Yusof.pdf
23. Afzaninawati Suria Y, Zaleha MI, Shamsul Azhar Shah. Dietary patterns and risk of colorectal
cancer: a systematic review of cohort studies (2000-2011). Asian Pac J Cancer Prev
2012;13(9):4713-4717
http://www.apocpcontrol.org/paper_file/issue_abs/Volume13_No9/47137%208.16%20Afzaninawati%20Suria%20Yusof.pdf
24. Syahnaz MH, Khairani O, Tong SF, et al. Factors influencing late consultation among patients with
rectal bleeding in University Kebangsaan Malaysia Medical Centre. Asian Pac J Cancer Prev
2010;11(5):1335-1339
http://www.apocpcontrol.org/paper_file/issue_abs/Volume11_No5/c%20133539%209.27%20Ismail%20Sagap.pdf
25. Syahnaz MH, Tong SF, Khairani O, et al. Knowledge of colorectal cancer among patients
presenting with rectal bleeding and its association with delay in seeking medical advice. Asian
Pac J Cancer Prev 2011;12(8):2007-2011
http://www.apocpcontrol.org/paper_file/issue_abs/Volume12_No8/200711%20c7.28%20Hashim.pdf
26. Ahmed SA, Rand RH, Layla KM, et al. Investigation into the controversial association of
Streptococcus gallolyticus with colorectal cancer and adenoma. BMC Cancer 2009;9:403-2407-9403
http://www.biomedcentral.com.ezp.imu.edu.my/content/pdf/1471-2407-9-403.pdf
Page 3 of 10
27. Abdul Aziz AA, Siti Nurfatimah MS, Mohd Aminudin M, et al. Association of Arg72Pro of P53
polymorphism with colorectal cancer susceptibility risk in Malaysian population. Asian Pac J
Cancer Prev 2011;12(11):2909-2913
http://www.apocpcontrol.org/paper_file/issue_abs/Volume12_No11/290913%20c10.19%20Aizat.pdf
28. Ahmed SA, Rand RH, Fatimah AB. The association of Streptococcus bovis/gallolyticus with
colorectal tumors: the nature and the underlying mechanisms of its etiological role. J Exp Clin
Cancer Res 2011;30:11-9966-30-11
http://www.jeccr.com/content/pdf/1756-9966-30-11.pdf
29. Ahmed SA, Rand RH, Fatimah AB. Molecular detection, quantification, and isolation of
Streptococcus gallolyticus bacteria colonizing colorectal tumors: inflammation-driven potential of
carcinogenesis via IL-1, COX-2, and IL-8. Mol Cancer 2010;9:249-4598-9-249
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2946291/pdf/1476-4598-9-249.pdf
30. Balraj P, Ruhana S. PTEN mutation studies in Malaysian colorectal cancer patients. Asia Pacific
Journal of Molecular Biology and Biotechnology 2007;15(1):23-25
http://www.msmbb.org.my/apjmbb/html151/151d.pdf
31. Chandramathi S, Suresh KG, Anita ZB, et al. Attenuation of hydrogen peroxide and ferric
reducing/antioxidant power serum levels in colorectal cancer patients with intestinal parasitic
infection. Malays J Med Sci 2009;16(2):15-20
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3336169/pdf/mjms-16-2-015.pdf
32. Lim SR, Gooi BH, Singh M, et al. Analysis of differentially expressed proteins in colorectal cancer
using hydroxyapatite column and SDS-PAGE. Appl Biochem Biotechnol 2011;165(5-6):1211-1224.
33. Hilmi I, Goh KL. Commentary: adherence and detection rates in colorectal cancer screening.
Aliment Pharmacol Ther 2013;37(1):156-7; discussion 157-8.
34. Koo JH, Leong RW, Ching J, et al. Knowledge of, attitudes toward, and barriers to participation of
colorectal cancer screening tests in the Asia-Pacific region: a multicenter study. Gastrointest
Endosc 2012;76(1):126-135.
35. Wendy L, Radzi M. New registry: National Cancer Patient Registry--Colorectal Cancer. Med J
Malaysia 2008;63 Suppl C:57-58.
36. Mirakhorli M, Rahman SA, Abdullah S, et al. Multidrug resistance protein 2 genetic
polymorphism and colorectal cancer recurrence in patients receiving adjuvant FOLFOX-4
chemotherapy. Mol Med Rep 2013;7(2):613-617.
37. Ho K, Yazan LS, Ismail N, et al. Apoptosis and cell cycle arrest of human colorectal cancer cell line
HT-29 induced by vanillin. Cancer Epidemiol 2009;33(2):155-160.
Page 4 of 10
38. Tan YM, Rosmawati M, Ranjeev P, et al. Predictive factors by multivariate analysis for colorectal
cancer in Malaysian patients undergoing colonoscopy. J Gastroenterol Hepatol 2002;17(3):281284.
39. Roslani AC, Abdullah T, Arumugam K. Screening for colorectal neoplasias with fecal occult blood
tests: false-positive impact of non-dietary restriction. Asian Pac J Cancer Prev 2012;13(1):237241.
40. Ghazali AK, Musa KI, Naing NN, et al. Prognostic factors in patients with colorectal cancer at
Hospital Universiti Sains Malaysia. Asian J Surg 2010;33(3):127-133.
41. Goh KL. Changing trends in gastrointestinal disease in the Asia-Pacific region. J Dig Dis
2007;8(4):179-185.
42. Tan LP, Ng BK, Balraj P, et al. No difference in the occurrence of mismatch repair defects and APC
and CTNNB1 genes mutation in a multi-racial colorectal carcinoma patient cohort. Pathology
2007;39(2):228-234.
43. Yip WK, Choo CW, Leong VC, et al. Molecular alterations of Ras-Raf-mitogen-activated protein
kinase and phosphatidylinositol 3-kinase-Akt signaling pathways in colorectal cancers from a
tertiary hospital at Kuala Lumpur, Malaysia. APMIS 2013;121(10):954-966.
44. Abdul Murad NA, Othman Z, Khalid M, et al. Missense mutations in MLH1, MSH2, KRAS, and APC
genes in colorectal cancer patients in Malaysia. Dig Dis Sci 2012;57(11):2863-2872.
45. Davoodi H, Seow HF. Variant Toll-like receptor4 (Asp299Gly and Thr399Ile alleles) and Toll-like
receptor2 (Arg753Gln and Arg677Trp alleles) in colorectal cancer. Iran J Allergy Asthma Immunol
2011;10(2):91-99.
46. Zulhabri O, Rahman J, Ismail S, et al. Predominance of G to A codon 12 mutation K-ras gene in
Dukes' B colorectal cancer. Singapore Med J 2012;53(1):26-31
http://www.ncbi.nlm.nih.gov/pubmed/22252179
47. Yam YY, Hoh BP, Othman NH, et al. Somatic copy-neutral loss of heterozygosity and copy number
abnormalities in Malaysian sporadic colorectal carcinoma patients. Genet Mol Res
2013;12(1):319-327.
48. Ching-Shian Leong V, Jabal MF, Leong PP, et al. PIK3CA gene mutations in breast carcinoma in
Malaysian patients. Cancer Genet Cytogenet 2008;187(2):74-79.
49. Harmy MY, Norwati D, Noor NM, et al. Knowledge and attitude of colorectal cancer screening
among moderate risk patients in West Malaysia. Asian Pac J Cancer Prev 2011;12(8):1957-1960.
50. Hilmi I, Hartono JL, Goh K. Negative perception in those at highest risk--potential challenges in
colorectal cancer screening in an urban asian population. Asian Pac J Cancer Prev
2010;11(3):815-822.
51. Gul YA. Management of colorectal cancer--can we do better? Med J Malaysia 2008;63(2):89-90
http://www.e-mjm.org/2008/v63n2/Colorectal_Cancer.pdf
Page 5 of 10
52. Chandramathi S, Suresh K, Anita ZB, et al. Infections of Blastocystis hominis and microsporidia in
cancer patients: are they opportunistic? Trans R Soc Trop Med Hyg 2012;106(4):267-269.
53. Kamil M, Haron M, Yosuff N, et al. High frequency of hand foot syndrome with capecitabine. J
Coll Physicians Surg Pak 2010;20(6):421-422.
54. Ng CV. Hypersensitivity reactions to oxaliplatin in two asian patients. Ann Pharmacother
2005;39(6):1114-1118.
55. Dranitsaris G, Truter I, Lubbe MS. The development of a value based pricing index for new drugs
in metastatic colorectal cancer. Eur J Cancer 2011;47(9):1299-1304.
56. Tan BS, Tiong KH, Muruhadas A, et al. CYP2S1 and CYP2W1 mediate 2-(3,4-dimethoxyphenyl)-5fluorobenzothiazole (GW-610, NSC 721648) sensitivity in breast and colorectal cancer cells. Mol
Cancer Ther 2011;10(10):1982-1992.
57. Amutha R, Mirnalini K. Food intake and colorectal adenomas: a case-control study in Malaysia.
Asian Pac J Cancer Prev 2009;10(5):925-932
http://www.apocpcontrol.org/paper_file/issue_abs/Volume10_No5/925%20Ramadas.pdf
58. Khor TO, Gul YA, Ithnin H, et al. Positive correlation between overexpression of phospho-BAD
with phosphorylated Akt at serine 473 but not threonine 308 in colorectal carcinoma. Cancer Lett
2004;210(2):139-150.
59. Khor TO, Gul YA, Ithnin H, et al. A comparative study of the expression of Wnt-1, WISP-1, survivin
and cyclin-D1 in colorectal carcinoma. Int J Colorectal Dis 2006;21(4):291-300.
60. Chan KH, Chandramathi S, Suresh K, et al. Effects of symptomatic and asymptomatic isolates of
Blastocystis hominis on colorectal cancer cell line, HCT116. Parasitol Res 2012;110(6):2475-2480.
61. Chandramathi S, Suresh K, Kuppusamy UR. Solubilized antigen of Blastocystis hominis facilitates
the growth of human colorectal cancer cells, HCT116. Parasitol Res 2010;106(4):941-945.
62. Jada SR, Lim R, Wong CI, et al. Role of UGT1A1*6, UGT1A1*28 and ABCG2 c.421C>A
polymorphisms in irinotecan-induced neutropenia in Asian cancer patients. Cancer Sci
2007;98(9):1461-1467.
63. Yaacob NS, Darus HM, Norazmi MN. Modulation of cell growth and PPARgamma expression in
human colorectal cancer cell lines by ciglitazone. Exp Toxicol Pathol 2008;60(6):505-512.
64. Hilmi I, Goh KL. Chemoprevention of colorectal cancer with nonsteroidal anti-inflammatory
drugs. Chin J Dig Dis 2006;7(1):1-6.
65. Hong SK, Gul YA, Ithnin H, et al. Expression of beta-catenin, COX-2 and iNOS in colorectal cancer:
relevance of COX-2 adn iNOS inhibitors for treatment in Malaysia. Asian J Surg 2004;27(1):10-17.
66. Teoh CM, Gunasegaram T, Chan KY, et al. Review of risk factors associated with the anastomosis
leakage in anterior resection in Hospital Universiti Kebangsaan Malaysia. Med J Malaysia
2005;60(3):275-280
Page 6 of 10
http://www.e-mjm.org/2005/v60n3/Anastomosis_Leakage.pdf
67. Naik VR, Jaafar H, Seng CE. Lymphatic channel density in colorectal adenocarcinoma. Indian J
Pathol Microbiol 2010;53(1):12-14.
68. bin Sabir Husin Athar PP, bte Ahmad Norhan N, bin Saim L, et al. Metastasis to the sinonasal tract
from sigmoid colon adenocarcinoma. Ann Acad Med Singapore 2008;37(9):788-783.
69. Rajendra S, Ho JJ, Arokiasamy J. Risk of colorectal adenomas in a multiethnic Asian patient
population: race does not matter. J Gastroenterol Hepatol 2005;20(1):51-55.
70. Goh KS, Ong TA, Peh SC, et al. P53 expression in colorectal carcinoma: the University of Malaya
Medical Centre's experience. Med J Malaysia 2004;59(4):515-521
http://www.e-mjm.org/2004/v59n4/Colorectal_Carcinoma.pdf
71. Natrah MS, Ezat S, Syed MA, et al. Quality of life in Malaysian colorectal cancer patients: a
preliminary result. Asian Pac J Cancer Prev 2012;13(3):957-962.
72. Mahadeva S, Rembacken BJ. Standard "inject and cut" endoscopic mucosal resection technique
is practical and effective in the management of superficial colorectal neoplasms. Surg Endosc
2009;23(2):417-422.
73. Chandramathi S, Suresh K, Anita ZB, et al. Comparative assessment of urinary oxidative indices in
breast and colorectal cancer patients. J Cancer Res Clin Oncol 2009;135(2):319-323.
74. Primrose JN. Managing liver metastases: myth or reality? Med J Malaysia 2005;60 Suppl B:67-69.
75. Chan SH, Ng C, Looi LM. Intraoperative methylene blue sentinel lymph node mapping in
colorectal cancer. ANZ J Surg 2008;78(9):775-779.
76. Chan TH, Goh KL. Appropriateness of colonoscopy using the ASGE guidelines: experience in a
large Asian hospital. Chin J Dig Dis 2006;7(1):24-32.
77. Lim MS, Melich G, Min BS. Robotic single-incision anterior resection for sigmoid colon cancer:
access port creation and operative technique. Surg Endosc 2013;27(3):1021-012-2549-0. Epub
2012 Oct 10.
78. Cheong KL, Roohi S, Jarmin R, et al. The yield for colorectal cancer and adenoma by indication at
colonoscopy. Med J Malaysia 2000;55(4):464-466
http://www.e-mjm.org/2000/v55n4/Colonoscopy.pdf.
79. Lim SR, Gooi BH, Gam LH. Identification of low abundance proteins in colorectal cancer tissues.
Cancer Biomark 2012;12(4):185-198.
80. Goh KL, Quek KF, Yeo GT, et al. Colorectal cancer in Asians: a demographic and anatomic survey
in Malaysian patients undergoing colonoscopy. Aliment Pharmacol Ther 2005;22(9):859-864.
Page 7 of 10
81. Aisha AF, Abu-Salah KM, Ismail Z, et al. alpha-Mangostin enhances betulinic acid cytotoxicity and
inhibits cisplatin cytotoxicity on HCT 116 colorectal carcinoma cells. Molecules 2012;17(3):29392954.
82. Nassar ZD, Aisha AF, Idris N, et al. Koetjapic acid, a natural triterpenoid, induces apoptosis in
colon cancer cells. Oncol Rep 2012;27(3):727-733.
83. Ashok Kumar P, Norhaizan ME. Dietary non-nutritive factors in targeting of regulatory molecules
in colorectal cancer: an update. Asian Pac J Cancer Prev 2013;14(10):5543-5552
http://www.apocpcontrol.org/paper_file/issue_abs/Volume14_No10/55435552%207.25%20Ashok%20Kumar%20Pandurangan%20%28REVIEW%29.pdf
84. Leong BD, Ramu P, Kumar VM, et al. Synchronous adenocarcinoma of caecum, transverse colon
and jejunum. Med J Malaysia 2008;63(2):148-149
http://www.e-mjm.org/2008/v63n2/Synchronous_Adenocarcinoma.pdf
85. Rajendra S, Kutty K, Karim N. Flat colonic adenomas in Malaysia: fact or fancy? J Gastroenterol
Hepatol 2003;18(6):701-704.
86. Tan LP, Ng BK, Balraj P, et al. Gene symbol: APC. Disease: colorectal cancer. Hum Genet
2005;118(3-4):545.
87. Venkatesh RN, Jaafar H, Mutum SS. Heterotopic ossification in skeletal muscle metastasis from
colonic adenocarcinoma--a case report. Malays J Pathol 2005;27(2):119-121
http://www.mjpath.org.my/past_issue/MJP2005.2/08Heteropic.pdf
88. Harris Ngow A, Wan Khairina W. Cardiac mass in a patient with sigmoid adenocarcinoma: a
metastasis? Cardiovasc J Afr 2012;23(7):e10-e12
http://search.ebscohost.com/login.aspx?direct=true&db=mdc&AN=22915057&site=ehost-live
89. Chan KY, Teoh CM, Sukumar N. Chylous ascites after anterior resection for rectal carcinoma: a
rare but significant incident. Asian J Surg 2006;29(1):46-48.
90. Hisham RB, Thuaibah H, Gul YA. Mucinous adenocarcinoma of the rectum with breast and ocular
metastases. Asian J Surg 2006;29(2):95-97.
91. Jasman J, Mayuha R, Imtiaz H, et al. Subcutaneous metastases from rectal carcinoma: A case
report. Journal of Surgical Academia 2011;1(2):23
http://journalarticle.ukm.my/2960/1/23-24.pdf
92. Law CW, Roslani AC, Ng LL. Treatment delay in rectal cancer. Med J Malaysia 2009;64(2):163-165.
93. Lee WC, Mastura MY, Lau FN, et al. Preoperative long course chemoirradiation in a developing
country for rectal carcinoma: Kuala Lumpur Hospital experience. Asian Pac J Cancer Prev
2013;14(6):3941-3944
Page 8 of 10
http://www.apocpcontrol.org/paper_file/issue_abs/Volume14_No6/3941-44%205.27%20Wei
%20Ching%20Lee.pdf
94. Ramanathan Y, Rajagopalan R, Rahman NA. Laryngeal metastasis from a rectal carcinoma. Ear
Nose Throat J 2007;86(11):685-686.
95. Siti Aisyah AG, Maznah I, Latifah SY, et al. Cytotoxic Activity of Kenaf Seed Oils from Supercritical
Carbon Dioxide Fluid Extraction towards Human Colorectal Cancer (HT29) Cell Lines. Evid Based
Complement Alternat Med 2013;2013:549705
http://www.hindawi.com/journals/ecam/2013/549705/
96. Al-Joudi FS. Prognostic value of an index for serum globulin compensation in colon and breast
cancers. Singapore Med J 2005;46(12):710-713
http://www.sma.org.sg/smj/4612/4612a5.pdf
97. Nazri A, Lio P. Investigating meta-approaches for reconstructing gene networks in a mammalian
cellular context. PLoS One 2012;7(1):e28713
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3253778/
98. Ahmad Aizat AA, Siti Nurfatimah MS, Aminudin MM, et al. XPC Lys939Gln polymorphism,
smoking and risk of sporadic colorectal cancer among Malaysians. World J Gastroenterol
2013;19(23):3623-3628
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3691041/
99. Chan KK, Dassanayake B, Deen R, et al. Young patients with colorectal cancer have poor survival
in the first twenty months after operation and predictable survival in the medium and long-term:
analysis of survival and prognostic markers. World J Surg Oncol 2010;8:82-7819-8-82
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2954852/
100.
Kaur G, Masoud A, Raihan N, et al. Mismatch repair genes expression defects & association
with clinicopathological characteristics in colorectal carcinoma. Indian J Med Res 2011;134:186192
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3181019/
101.
Liong MT. Roles of probiotics and prebiotics in colon cancer prevention: Postulated
mechanisms and in-vivo evidence. Int J Mol Sci 2008;9(5):854-863
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2635701/
102.
Mustapha MA, Shahpudin SN, Aziz AA, et al. Risk modification of colorectal cancer
susceptibility by interleukin-8 -251T>A polymorphism in Malaysians. World J Gastroenterol
2012;18(21):2668-2673
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3370004/
Page 9 of 10
103.
Safari A, Shariff ZM, Kandiah M, et al. Dietary patterns and risk of colorectal cancer in Tehran
Province: a case-control study. BMC Public Health 2013;13:222-2458-13-222
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3605096/
104.
Wasito I, Hashim SZ, Sukmaningrum S. Iterative local Gaussian clustering for expressed genes
identification linked to malignancy of human colorectal carcinoma. Bioinformation
2007;2(5):175-181
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2241931/
105.
Wong TW, Colombo G, Sonvico F. Pectin matrix as oral drug delivery vehicle for colon cancer
treatment. AAPS PharmSciTech 2011;12(1):201-214
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3066368/
106.
Yeoh LC, Dharmaraj S, Gooi BH, et al. Chemometrics of differentially expressed proteins from
colorectal cancer patients. World J Gastroenterol 2011;17(16):2096-2103
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3084394/
107.
Yeoh LC, Loh CK, Gooi BH, et al. Hydrophobic protein in colorectal cancer in relation to tumor
stages and grades. World J Gastroenterol 2010;16(22):2754-2763
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2883131/
108.
Yip KT, Das PK, Suria D, et al. A case-controlled validation study of a blood-based seven-gene
biomarker panel for colorectal cancer in Malaysia. J Exp Clin Cancer Res 2010;29:128-9966-29128
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2949823/
109.
Zahary MN, Kaur G, Abu Hassan MR, et al. Germline mutation analysis of MLH1 and MSH2 in
Malaysian Lynch syndrome patients. World J Gastroenterol 2012;18(8):814-820
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3286145/
Page 10 of 10
1. Fadli A, Azmi M, David O, et al. Isolated metacarpal bone metastasis from advanced rectosigmoid
carcinoma. International Medical Journal (IIUM) 2012;11(1):52-62
http://iiumedic.net/imjm/v1/download/Volume%2011%20No%201/IMJM%20Vol11No1-2012p59-62.pdf
2. Magaji BA, Moy FM, April Camilla R, et al. Health-related quality of life among colorectal cancer
patients in Malaysia: a study protocol. BMC Cancer 2012;12:384-2407-12-384
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3443003/
3. Rajendra S, Ho JJ. Colonic diverticular disease in a multiracial Asian patient population has an
ethnic predilection. Eur J Gastroenterol Hepatol 2005;17(8):871-875.
4. Azmi MN, Zailani MA, Norashikin MN, et al. Five-year review of histopathological findings of
colorectal cancer patients operated in Hospital Tengku Ampuan Afzan, Kuantan, Pahang,
Malaysia. International Medical Journal (IIUM) 2007;6(1)
http://www.e-imj.com/Vol6-No1/Vol6-No1-B3.htm
5. Mohamed AQ. Consensus/Clinical Practice Guidelines on Screening for Colorectal Cancer in
Malaysia. Malaysian Society of Gastroenterology & Hepatology, College of Surgeons of Malaysia,
Academy of Medicine of Malaysia 2001;.
6. Qureshi MA. Consensus/Clinical Practice Guidelines on Screening for Colorectal Cancer in
Malaysia. 2001;.
7. Chew MF, Teoh KH, Cheah PL. CD133 marks for colorectal adenocarcinoma. Malays J Pathol
2012;34(1):25-28
http://www.mjpath.org.my/2012.1/CD133.pdf
8. Sharifa Ezat WP, Natrah MS, Syed Mohd A, et al. Quality of life in Malaysian colorectal cancer
patients. Asia Pac Psychiatry 2013;5 Suppl 1:110-117
http://onlinelibrary.wiley.com/doi/10.1111/appy.12055/pdf
9. Loh KW, Hazreen AM, Maznah D, et al. Sociodemographic predictors of recall and recognition of
colorectal cancer symptoms and anticipated delay in help- seeking in a multiethnic asian
population. Asian Pac J Cancer Prev 2013;14(6):3799-3804
http://www.apocpcontrol.org/paper_file/issue_abs/Volume14_No6/3799804%205.19%20Kwong%20Weng%20Loh.pdf
10. 10. Yunus AG. Surgical management of rectal cancer - no room for error. Malaysian Journal of
Medicine and Health Sciences 2008;4(1):iii-iv
http://medic.upm.edu.my/images/stories/journal/VOL4NO1_JANUARY2008.pdf
Page 1 of 10
11. Al-Naggar RA, Bobryshev YV. Knowledge of colorectal cancer screening among young Malaysians.
Asian Pac J Cancer Prev 2013;14(3):1969-1974
http://www.apocpcontrol.org/paper_file/issue_abs/Volume14_No3/%20196974%202.21%20Redhwan%20A%20Al-Naggar.pdf
12. Zahary MN, Ahmad Aizat AA, Gurjeet Kaur, et al. Contribution of the MLH1 -93G>a promoter
polymorphism in modulating susceptibility risk in Malaysian colorectal cancer patients. Asian Pac
J Cancer Prev 2013;14(2):619-624
http://www.apocpcontrol.org/paper_file/issue_abs/Volume14_No2/619-624%208.13%20Zahary
%20Mohd%20Nizam.pdf
13. Harmy MY, Norwati D, Norhayati MN, et al. Participation and barriers to colorectal cancer
screening in Malaysia. Asian Pac J Cancer Prev 2012;13(8):3983-3987
http://www.apocpcontrol.org/paper_file/issue_abs/Volume13_No8/3983-87%207.24%20Harmy
%20Mohamed%20Yusof.pdf
14. 14. Ulaganathan V, Kandiah M, Zalilah MS, et al. Colorectal cancer and its association with the
metabolic syndrome: a Malaysian multi-centric case-control study. Asian Pac J Cancer Prev
2012;13(8):3873-3877
http://www.apocpcontrol.org/paper_file/issue_abs/Volume13_No8/387377%207.16%20Vaidehi%20Ulaganathan.pdf
15. Ashwaq Hamid Y, Narazah MY, Imran AK, et al. Pilot study of the sensitivity and specificity of the
DNA integrity assay for stool-based detection of colorectal cancer in Malaysian patients. Asian
Pac J Cancer Prev 2012;13(5):1869-1872
http://www.apocpcontrol.org/paper_file/issue_abs/Volume13_No5/1869-72%204.1%20Ashwaq
%20Hamid%20Yehya.pdf
16. Al-Jashamy K, Murad A, Zeehaida M, et al. Prevalence of colorectal cancer associated with
Streptococcus bovis among inflammatory bowel and chronic gastrointestinal tract disease
patients. Asian Pac J Cancer Prev 2010;11(6):1765-1768
http://www.apocpcontrol.org/paper_file/issue_abs/Volume11_No6/c%20176568%2010.20%20Al-Jashamy%20Karim.pdf
17. Kong C, April Camilla R, Law C, et al. Impact of socio-economic class on colorectal cancer patient
outcomes in Kuala Lumpur and Kuching, Malaysia. Asian Pac J Cancer Prev 2010;11(4):969-974
http://www.apocpcontrol.org/paper_file/issue_abs/Volume11_No4/c%20969-74%20Kong.pdf
18. Nor Hayati O, Anani Aila MZ. Association of colorectal carcinoma with metabolic diseases;
experience with 138 cases from Kelantan, Malaysia. Asian Pac J Cancer Prev 2008;9(4):747-751
http://www.apocpcontrol.org/paper_file/issue_abs/Volume9_No4/747%20c%20Othman.pdf
Page 2 of 10
19. Mohd Radzniwan AR, Aznida Firzah AA, Saharuddin A, et al. Colorectal cancer patients in a
tertiary referral centre in Malaysia: a five year follow-up review. Asian Pac J Cancer Prev
2009;10(6):1163-1166
http://www.apocpcontrol.org/paper_file/issue_abs/Volume10_No6/1163_c_Rashid.pdf
20. Mirnalini K, Amutha R, Zalilah MS, et al. Diet and lifestyle intervention among patients with
colorectal adenomas: rationale and design of a Malaysian study. Asian Pac J Cancer Prev
2005;6(4):553-560
http://www.apocpcontrol.org/paper_file/issue_abs/Volume6_No4/Mirnalini%20Kandiah.pdf
21. Husna AA, Loh SY, Low WY, et al. Quality of life of multiethnic adolescents living with a parent
with cancer. Asian Pac J Cancer Prev 2012;13(12):6289-6294
http://www.apocpcontrol.org/paper_file/issue_abs/Volume13_No12/628994%2011.10%20Husna%20A%20Ainuddin.pdf
22. Afzaninawati Suria Y, Zaleha MI, Shamsul Azhar Shah. Perceptions of Malaysian colorectal cancer
patients regarding dietary intake: a qualitative exploration. Asian Pac J Cancer Prev
2013;14(2):1151-1154
http://www.apocpcontrol.org/paper_file/issue_abs/Volume14_No2/115154%201.4%20Afzaninawati%20Suria%20Yusof.pdf
23. Afzaninawati Suria Y, Zaleha MI, Shamsul Azhar Shah. Dietary patterns and risk of colorectal
cancer: a systematic review of cohort studies (2000-2011). Asian Pac J Cancer Prev
2012;13(9):4713-4717
http://www.apocpcontrol.org/paper_file/issue_abs/Volume13_No9/47137%208.16%20Afzaninawati%20Suria%20Yusof.pdf
24. Syahnaz MH, Khairani O, Tong SF, et al. Factors influencing late consultation among patients with
rectal bleeding in University Kebangsaan Malaysia Medical Centre. Asian Pac J Cancer Prev
2010;11(5):1335-1339
http://www.apocpcontrol.org/paper_file/issue_abs/Volume11_No5/c%20133539%209.27%20Ismail%20Sagap.pdf
25. Syahnaz MH, Tong SF, Khairani O, et al. Knowledge of colorectal cancer among patients
presenting with rectal bleeding and its association with delay in seeking medical advice. Asian
Pac J Cancer Prev 2011;12(8):2007-2011
http://www.apocpcontrol.org/paper_file/issue_abs/Volume12_No8/200711%20c7.28%20Hashim.pdf
26. Ahmed SA, Rand RH, Layla KM, et al. Investigation into the controversial association of
Streptococcus gallolyticus with colorectal cancer and adenoma. BMC Cancer 2009;9:403-2407-9403
http://www.biomedcentral.com.ezp.imu.edu.my/content/pdf/1471-2407-9-403.pdf
Page 3 of 10
27. Abdul Aziz AA, Siti Nurfatimah MS, Mohd Aminudin M, et al. Association of Arg72Pro of P53
polymorphism with colorectal cancer susceptibility risk in Malaysian population. Asian Pac J
Cancer Prev 2011;12(11):2909-2913
http://www.apocpcontrol.org/paper_file/issue_abs/Volume12_No11/290913%20c10.19%20Aizat.pdf
28. Ahmed SA, Rand RH, Fatimah AB. The association of Streptococcus bovis/gallolyticus with
colorectal tumors: the nature and the underlying mechanisms of its etiological role. J Exp Clin
Cancer Res 2011;30:11-9966-30-11
http://www.jeccr.com/content/pdf/1756-9966-30-11.pdf
29. Ahmed SA, Rand RH, Fatimah AB. Molecular detection, quantification, and isolation of
Streptococcus gallolyticus bacteria colonizing colorectal tumors: inflammation-driven potential of
carcinogenesis via IL-1, COX-2, and IL-8. Mol Cancer 2010;9:249-4598-9-249
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2946291/pdf/1476-4598-9-249.pdf
30. Balraj P, Ruhana S. PTEN mutation studies in Malaysian colorectal cancer patients. Asia Pacific
Journal of Molecular Biology and Biotechnology 2007;15(1):23-25
http://www.msmbb.org.my/apjmbb/html151/151d.pdf
31. Chandramathi S, Suresh KG, Anita ZB, et al. Attenuation of hydrogen peroxide and ferric
reducing/antioxidant power serum levels in colorectal cancer patients with intestinal parasitic
infection. Malays J Med Sci 2009;16(2):15-20
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3336169/pdf/mjms-16-2-015.pdf
32. Lim SR, Gooi BH, Singh M, et al. Analysis of differentially expressed proteins in colorectal cancer
using hydroxyapatite column and SDS-PAGE. Appl Biochem Biotechnol 2011;165(5-6):1211-1224.
33. Hilmi I, Goh KL. Commentary: adherence and detection rates in colorectal cancer screening.
Aliment Pharmacol Ther 2013;37(1):156-7; discussion 157-8.
34. Koo JH, Leong RW, Ching J, et al. Knowledge of, attitudes toward, and barriers to participation of
colorectal cancer screening tests in the Asia-Pacific region: a multicenter study. Gastrointest
Endosc 2012;76(1):126-135.
35. Wendy L, Radzi M. New registry: National Cancer Patient Registry--Colorectal Cancer. Med J
Malaysia 2008;63 Suppl C:57-58.
36. Mirakhorli M, Rahman SA, Abdullah S, et al. Multidrug resistance protein 2 genetic
polymorphism and colorectal cancer recurrence in patients receiving adjuvant FOLFOX-4
chemotherapy. Mol Med Rep 2013;7(2):613-617.
37. Ho K, Yazan LS, Ismail N, et al. Apoptosis and cell cycle arrest of human colorectal cancer cell line
HT-29 induced by vanillin. Cancer Epidemiol 2009;33(2):155-160.
Page 4 of 10
38. Tan YM, Rosmawati M, Ranjeev P, et al. Predictive factors by multivariate analysis for colorectal
cancer in Malaysian patients undergoing colonoscopy. J Gastroenterol Hepatol 2002;17(3):281284.
39. Roslani AC, Abdullah T, Arumugam K. Screening for colorectal neoplasias with fecal occult blood
tests: false-positive impact of non-dietary restriction. Asian Pac J Cancer Prev 2012;13(1):237241.
40. Ghazali AK, Musa KI, Naing NN, et al. Prognostic factors in patients with colorectal cancer at
Hospital Universiti Sains Malaysia. Asian J Surg 2010;33(3):127-133.
41. Goh KL. Changing trends in gastrointestinal disease in the Asia-Pacific region. J Dig Dis
2007;8(4):179-185.
42. Tan LP, Ng BK, Balraj P, et al. No difference in the occurrence of mismatch repair defects and APC
and CTNNB1 genes mutation in a multi-racial colorectal carcinoma patient cohort. Pathology
2007;39(2):228-234.
43. Yip WK, Choo CW, Leong VC, et al. Molecular alterations of Ras-Raf-mitogen-activated protein
kinase and phosphatidylinositol 3-kinase-Akt signaling pathways in colorectal cancers from a
tertiary hospital at Kuala Lumpur, Malaysia. APMIS 2013;121(10):954-966.
44. Abdul Murad NA, Othman Z, Khalid M, et al. Missense mutations in MLH1, MSH2, KRAS, and APC
genes in colorectal cancer patients in Malaysia. Dig Dis Sci 2012;57(11):2863-2872.
45. Davoodi H, Seow HF. Variant Toll-like receptor4 (Asp299Gly and Thr399Ile alleles) and Toll-like
receptor2 (Arg753Gln and Arg677Trp alleles) in colorectal cancer. Iran J Allergy Asthma Immunol
2011;10(2):91-99.
46. Zulhabri O, Rahman J, Ismail S, et al. Predominance of G to A codon 12 mutation K-ras gene in
Dukes' B colorectal cancer. Singapore Med J 2012;53(1):26-31
http://www.ncbi.nlm.nih.gov/pubmed/22252179
47. Yam YY, Hoh BP, Othman NH, et al. Somatic copy-neutral loss of heterozygosity and copy number
abnormalities in Malaysian sporadic colorectal carcinoma patients. Genet Mol Res
2013;12(1):319-327.
48. Ching-Shian Leong V, Jabal MF, Leong PP, et al. PIK3CA gene mutations in breast carcinoma in
Malaysian patients. Cancer Genet Cytogenet 2008;187(2):74-79.
49. Harmy MY, Norwati D, Noor NM, et al. Knowledge and attitude of colorectal cancer screening
among moderate risk patients in West Malaysia. Asian Pac J Cancer Prev 2011;12(8):1957-1960.
50. Hilmi I, Hartono JL, Goh K. Negative perception in those at highest risk--potential challenges in
colorectal cancer screening in an urban asian population. Asian Pac J Cancer Prev
2010;11(3):815-822.
51. Gul YA. Management of colorectal cancer--can we do better? Med J Malaysia 2008;63(2):89-90
http://www.e-mjm.org/2008/v63n2/Colorectal_Cancer.pdf
Page 5 of 10
52. Chandramathi S, Suresh K, Anita ZB, et al. Infections of Blastocystis hominis and microsporidia in
cancer patients: are they opportunistic? Trans R Soc Trop Med Hyg 2012;106(4):267-269.
53. Kamil M, Haron M, Yosuff N, et al. High frequency of hand foot syndrome with capecitabine. J
Coll Physicians Surg Pak 2010;20(6):421-422.
54. Ng CV. Hypersensitivity reactions to oxaliplatin in two asian patients. Ann Pharmacother
2005;39(6):1114-1118.
55. Dranitsaris G, Truter I, Lubbe MS. The development of a value based pricing index for new drugs
in metastatic colorectal cancer. Eur J Cancer 2011;47(9):1299-1304.
56. Tan BS, Tiong KH, Muruhadas A, et al. CYP2S1 and CYP2W1 mediate 2-(3,4-dimethoxyphenyl)-5fluorobenzothiazole (GW-610, NSC 721648) sensitivity in breast and colorectal cancer cells. Mol
Cancer Ther 2011;10(10):1982-1992.
57. Amutha R, Mirnalini K. Food intake and colorectal adenomas: a case-control study in Malaysia.
Asian Pac J Cancer Prev 2009;10(5):925-932
http://www.apocpcontrol.org/paper_file/issue_abs/Volume10_No5/925%20Ramadas.pdf
58. Khor TO, Gul YA, Ithnin H, et al. Positive correlation between overexpression of phospho-BAD
with phosphorylated Akt at serine 473 but not threonine 308 in colorectal carcinoma. Cancer Lett
2004;210(2):139-150.
59. Khor TO, Gul YA, Ithnin H, et al. A comparative study of the expression of Wnt-1, WISP-1, survivin
and cyclin-D1 in colorectal carcinoma. Int J Colorectal Dis 2006;21(4):291-300.
60. Chan KH, Chandramathi S, Suresh K, et al. Effects of symptomatic and asymptomatic isolates of
Blastocystis hominis on colorectal cancer cell line, HCT116. Parasitol Res 2012;110(6):2475-2480.
61. Chandramathi S, Suresh K, Kuppusamy UR. Solubilized antigen of Blastocystis hominis facilitates
the growth of human colorectal cancer cells, HCT116. Parasitol Res 2010;106(4):941-945.
62. Jada SR, Lim R, Wong CI, et al. Role of UGT1A1*6, UGT1A1*28 and ABCG2 c.421C>A
polymorphisms in irinotecan-induced neutropenia in Asian cancer patients. Cancer Sci
2007;98(9):1461-1467.
63. Yaacob NS, Darus HM, Norazmi MN. Modulation of cell growth and PPARgamma expression in
human colorectal cancer cell lines by ciglitazone. Exp Toxicol Pathol 2008;60(6):505-512.
64. Hilmi I, Goh KL. Chemoprevention of colorectal cancer with nonsteroidal anti-inflammatory
drugs. Chin J Dig Dis 2006;7(1):1-6.
65. Hong SK, Gul YA, Ithnin H, et al. Expression of beta-catenin, COX-2 and iNOS in colorectal cancer:
relevance of COX-2 adn iNOS inhibitors for treatment in Malaysia. Asian J Surg 2004;27(1):10-17.
66. Teoh CM, Gunasegaram T, Chan KY, et al. Review of risk factors associated with the anastomosis
leakage in anterior resection in Hospital Universiti Kebangsaan Malaysia. Med J Malaysia
2005;60(3):275-280
Page 6 of 10
http://www.e-mjm.org/2005/v60n3/Anastomosis_Leakage.pdf
67. Naik VR, Jaafar H, Seng CE. Lymphatic channel density in colorectal adenocarcinoma. Indian J
Pathol Microbiol 2010;53(1):12-14.
68. bin Sabir Husin Athar PP, bte Ahmad Norhan N, bin Saim L, et al. Metastasis to the sinonasal tract
from sigmoid colon adenocarcinoma. Ann Acad Med Singapore 2008;37(9):788-783.
69. Rajendra S, Ho JJ, Arokiasamy J. Risk of colorectal adenomas in a multiethnic Asian patient
population: race does not matter. J Gastroenterol Hepatol 2005;20(1):51-55.
70. Goh KS, Ong TA, Peh SC, et al. P53 expression in colorectal carcinoma: the University of Malaya
Medical Centre's experience. Med J Malaysia 2004;59(4):515-521
http://www.e-mjm.org/2004/v59n4/Colorectal_Carcinoma.pdf
71. Natrah MS, Ezat S, Syed MA, et al. Quality of life in Malaysian colorectal cancer patients: a
preliminary result. Asian Pac J Cancer Prev 2012;13(3):957-962.
72. Mahadeva S, Rembacken BJ. Standard "inject and cut" endoscopic mucosal resection technique
is practical and effective in the management of superficial colorectal neoplasms. Surg Endosc
2009;23(2):417-422.
73. Chandramathi S, Suresh K, Anita ZB, et al. Comparative assessment of urinary oxidative indices in
breast and colorectal cancer patients. J Cancer Res Clin Oncol 2009;135(2):319-323.
74. Primrose JN. Managing liver metastases: myth or reality? Med J Malaysia 2005;60 Suppl B:67-69.
75. Chan SH, Ng C, Looi LM. Intraoperative methylene blue sentinel lymph node mapping in
colorectal cancer. ANZ J Surg 2008;78(9):775-779.
76. Chan TH, Goh KL. Appropriateness of colonoscopy using the ASGE guidelines: experience in a
large Asian hospital. Chin J Dig Dis 2006;7(1):24-32.
77. Lim MS, Melich G, Min BS. Robotic single-incision anterior resection for sigmoid colon cancer:
access port creation and operative technique. Surg Endosc 2013;27(3):1021-012-2549-0. Epub
2012 Oct 10.
78. Cheong KL, Roohi S, Jarmin R, et al. The yield for colorectal cancer and adenoma by indication at
colonoscopy. Med J Malaysia 2000;55(4):464-466
http://www.e-mjm.org/2000/v55n4/Colonoscopy.pdf.
79. Lim SR, Gooi BH, Gam LH. Identification of low abundance proteins in colorectal cancer tissues.
Cancer Biomark 2012;12(4):185-198.
80. Goh KL, Quek KF, Yeo GT, et al. Colorectal cancer in Asians: a demographic and anatomic survey
in Malaysian patients undergoing colonoscopy. Aliment Pharmacol Ther 2005;22(9):859-864.
Page 7 of 10
81. Aisha AF, Abu-Salah KM, Ismail Z, et al. alpha-Mangostin enhances betulinic acid cytotoxicity and
inhibits cisplatin cytotoxicity on HCT 116 colorectal carcinoma cells. Molecules 2012;17(3):29392954.
82. Nassar ZD, Aisha AF, Idris N, et al. Koetjapic acid, a natural triterpenoid, induces apoptosis in
colon cancer cells. Oncol Rep 2012;27(3):727-733.
83. Ashok Kumar P, Norhaizan ME. Dietary non-nutritive factors in targeting of regulatory molecules
in colorectal cancer: an update. Asian Pac J Cancer Prev 2013;14(10):5543-5552
http://www.apocpcontrol.org/paper_file/issue_abs/Volume14_No10/55435552%207.25%20Ashok%20Kumar%20Pandurangan%20%28REVIEW%29.pdf
84. Leong BD, Ramu P, Kumar VM, et al. Synchronous adenocarcinoma of caecum, transverse colon
and jejunum. Med J Malaysia 2008;63(2):148-149
http://www.e-mjm.org/2008/v63n2/Synchronous_Adenocarcinoma.pdf
85. Rajendra S, Kutty K, Karim N. Flat colonic adenomas in Malaysia: fact or fancy? J Gastroenterol
Hepatol 2003;18(6):701-704.
86. Tan LP, Ng BK, Balraj P, et al. Gene symbol: APC. Disease: colorectal cancer. Hum Genet
2005;118(3-4):545.
87. Venkatesh RN, Jaafar H, Mutum SS. Heterotopic ossification in skeletal muscle metastasis from
colonic adenocarcinoma--a case report. Malays J Pathol 2005;27(2):119-121
http://www.mjpath.org.my/past_issue/MJP2005.2/08Heteropic.pdf
88. Harris Ngow A, Wan Khairina W. Cardiac mass in a patient with sigmoid adenocarcinoma: a
metastasis? Cardiovasc J Afr 2012;23(7):e10-e12
http://search.ebscohost.com/login.aspx?direct=true&db=mdc&AN=22915057&site=ehost-live
89. Chan KY, Teoh CM, Sukumar N. Chylous ascites after anterior resection for rectal carcinoma: a
rare but significant incident. Asian J Surg 2006;29(1):46-48.
90. Hisham RB, Thuaibah H, Gul YA. Mucinous adenocarcinoma of the rectum with breast and ocular
metastases. Asian J Surg 2006;29(2):95-97.
91. Jasman J, Mayuha R, Imtiaz H, et al. Subcutaneous metastases from rectal carcinoma: A case
report. Journal of Surgical Academia 2011;1(2):23
http://journalarticle.ukm.my/2960/1/23-24.pdf
92. Law CW, Roslani AC, Ng LL. Treatment delay in rectal cancer. Med J Malaysia 2009;64(2):163-165.
93. Lee WC, Mastura MY, Lau FN, et al. Preoperative long course chemoirradiation in a developing
country for rectal carcinoma: Kuala Lumpur Hospital experience. Asian Pac J Cancer Prev
2013;14(6):3941-3944
Page 8 of 10
http://www.apocpcontrol.org/paper_file/issue_abs/Volume14_No6/3941-44%205.27%20Wei
%20Ching%20Lee.pdf
94. Ramanathan Y, Rajagopalan R, Rahman NA. Laryngeal metastasis from a rectal carcinoma. Ear
Nose Throat J 2007;86(11):685-686.
95. Siti Aisyah AG, Maznah I, Latifah SY, et al. Cytotoxic Activity of Kenaf Seed Oils from Supercritical
Carbon Dioxide Fluid Extraction towards Human Colorectal Cancer (HT29) Cell Lines. Evid Based
Complement Alternat Med 2013;2013:549705
http://www.hindawi.com/journals/ecam/2013/549705/
96. Al-Joudi FS. Prognostic value of an index for serum globulin compensation in colon and breast
cancers. Singapore Med J 2005;46(12):710-713
http://www.sma.org.sg/smj/4612/4612a5.pdf
97. Nazri A, Lio P. Investigating meta-approaches for reconstructing gene networks in a mammalian
cellular context. PLoS One 2012;7(1):e28713
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3253778/
98. Ahmad Aizat AA, Siti Nurfatimah MS, Aminudin MM, et al. XPC Lys939Gln polymorphism,
smoking and risk of sporadic colorectal cancer among Malaysians. World J Gastroenterol
2013;19(23):3623-3628
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3691041/
99. Chan KK, Dassanayake B, Deen R, et al. Young patients with colorectal cancer have poor survival
in the first twenty months after operation and predictable survival in the medium and long-term:
analysis of survival and prognostic markers. World J Surg Oncol 2010;8:82-7819-8-82
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2954852/
100.
Kaur G, Masoud A, Raihan N, et al. Mismatch repair genes expression defects & association
with clinicopathological characteristics in colorectal carcinoma. Indian J Med Res 2011;134:186192
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3181019/
101.
Liong MT. Roles of probiotics and prebiotics in colon cancer prevention: Postulated
mechanisms and in-vivo evidence. Int J Mol Sci 2008;9(5):854-863
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2635701/
102.
Mustapha MA, Shahpudin SN, Aziz AA, et al. Risk modification of colorectal cancer
susceptibility by interleukin-8 -251T>A polymorphism in Malaysians. World J Gastroenterol
2012;18(21):2668-2673
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3370004/
Page 9 of 10
103.
Safari A, Shariff ZM, Kandiah M, et al. Dietary patterns and risk of colorectal cancer in Tehran
Province: a case-control study. BMC Public Health 2013;13:222-2458-13-222
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3605096/
104.
Wasito I, Hashim SZ, Sukmaningrum S. Iterative local Gaussian clustering for expressed genes
identification linked to malignancy of human colorectal carcinoma. Bioinformation
2007;2(5):175-181
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2241931/
105.
Wong TW, Colombo G, Sonvico F. Pectin matrix as oral drug delivery vehicle for colon cancer
treatment. AAPS PharmSciTech 2011;12(1):201-214
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3066368/
106.
Yeoh LC, Dharmaraj S, Gooi BH, et al. Chemometrics of differentially expressed proteins from
colorectal cancer patients. World J Gastroenterol 2011;17(16):2096-2103
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3084394/
107.
Yeoh LC, Loh CK, Gooi BH, et al. Hydrophobic protein in colorectal cancer in relation to tumor
stages and grades. World J Gastroenterol 2010;16(22):2754-2763
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2883131/
108.
Yip KT, Das PK, Suria D, et al. A case-controlled validation study of a blood-based seven-gene
biomarker panel for colorectal cancer in Malaysia. J Exp Clin Cancer Res 2010;29:128-9966-29128
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2949823/
109.
Zahary MN, Kaur G, Abu Hassan MR, et al. Germline mutation analysis of MLH1 and MSH2 in
Malaysian Lynch syndrome patients. World J Gastroenterol 2012;18(8):814-820
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3286145/
Page 10 of 10